Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 65(12): 1533-1544, 2016 12.
Article
in En
| MEDLINE
| ID: mdl-27714434
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Interleukin-2
/
Immunotherapy
/
Melanoma
/
Antineoplastic Agents
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
Germany